Cargando…
200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
BACKGROUND: Ceftriaxone (CRO) is commonly utilized for the treatment of Gram-negative infections. However, there are limited data on the appropriate dose of CRO for the treatment of Gram-negative bacteremia. This study aimed to assess the clinical outcomes of CRO 2 grams versus 1 gram daily for Gram...
Autores principales: | Huynh-Phan, Ricky, Zidaru, Andrei, Phe, Kady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677896/ http://dx.doi.org/10.1093/ofid/ofad500.273 |
Ejemplares similares
-
2811. Real-World Experience Utilizing Cefiderocol for Serious Multidrug Resistant Gram-Negative Infections
por: Teran, Nicholas S, et al.
Publicado: (2023) -
239. Comparing Alternative Treatment Options for Stenotrophomonas maltophilia bacteremia
por: Teran, Nicholas S, et al.
Publicado: (2023) -
Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score
por: Rajagopal, Sumanth, et al.
Publicado: (2017) -
Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010) -
258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)